Literature DB >> 22914296

Ulcerative colitis.

Ingrid Ordás1, Lars Eckmann, Mark Talamini, Daniel C Baumgart, William J Sandborn.   

Abstract

Ulcerative colitis is an idiopathic, chronic inflammatory disorder of the colonic mucosa, which starts in the rectum and generally extends proximally in a continuous manner through part of, or the entire, colon; however, some patients with proctitis or left-sided colitis might have a caecal patch of inflammation. Bloody diarrhoea is the characteristic symptom of the disease. The clinical course is unpredictable, marked by alternating periods of exacerbation and remission. In this Seminar we discuss the epidemiology, pathophysiology, diagnostic approach, natural history, medical and surgical management, and main disease-related complications of ulcerative colitis, and briefly outline novel treatment options. Enhanced understanding of how the interaction between environmental factors, genetics, and the immune system results in mucosal inflammation has increased knowledge of disease pathophysiology. We provide practical therapeutic algorithms that are easily applicable in daily clinical practice, emphasising present controversies in treatment management and novel therapies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914296     DOI: 10.1016/S0140-6736(12)60150-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  496 in total

1.  Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease.

Authors:  E Zittan; B Kabakchiev; R Milgrom; G C Nguyen; K Croitoru; A H Steinhart; M S Silverberg
Journal:  J Crohns Colitis       Date:  2016-01-18       Impact factor: 9.071

2.  Maresin 1 ameliorates iron-deficient anemia in IL-10(-/-) mice with spontaneous colitis by the inhibition of hepcidin expression though the IL-6/STAT3 pathway.

Authors:  Honggang Wang; Peiliang Shi; Chuanjiang Huang; Qinghong Liu
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

Review 3.  Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair.

Authors:  Anny-Claude Luissint; Charles A Parkos; Asma Nusrat
Journal:  Gastroenterology       Date:  2016-07-18       Impact factor: 22.682

4.  A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.

Authors:  Alison Ribeiro; Silvia Pontis; Luisa Mengatto; Andrea Armirotti; Valerio Chiurchiù; Valeria Capurro; Annalisa Fiasella; Andrea Nuzzi; Elisa Romeo; Guillermo Moreno-Sanz; Mauro Maccarrone; Angelo Reggiani; Giorgio Tarzia; Marco Mor; Fabio Bertozzi; Tiziano Bandiera; Daniele Piomelli
Journal:  ACS Chem Biol       Date:  2015-04-15       Impact factor: 5.100

Review 5.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

6.  Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life.

Authors:  Katharina A Schindlbeck; Janek Becker; Felix Berger; Arne Mehl; Charlotte Rewitzer; Sarah Geffe; Peter M Koch; Jan C Preiß; Britta Siegmund; Jochen Maul; Frank Marzinzik
Journal:  Int J Colorectal Dis       Date:  2016-10-18       Impact factor: 2.571

Review 7.  How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

Authors:  Jennifer Hutchison; Zoe Cohen; Benjamin C Onyeagucha; Janet Funk; Mark A Nelson
Journal:  Cancer Genet       Date:  2013-09-14

8.  WGCNA Reveals Key Roles of IL8 and MMP-9 in Progression of Involvement Area in Colon of Patients with Ulcerative Colitis.

Authors:  Xue Lin; Jin Li; Qiu Zhao; Jue-Rong Feng; Qian Gao; Jia-Yan Nie
Journal:  Curr Med Sci       Date:  2018-04-30

Review 9.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

10.  L-Glutamine and Physical Exercise Prevent Intestinal Inflammation and Oxidative Stress Without Improving Gastric Dysmotility in Rats with Ulcerative Colitis.

Authors:  Raisa de Oliveira Santos; Geovane da Silva Cardoso; Lara da Costa Lima; Mickael Laudrup de Sousa Cavalcante; Mariana Sousa Silva; Ana Karolina Martins Cavalcante; Juliana Soares Severo; Francisca Beatriz de Melo Sousa; Gabriella Pacheco; Even Herlany Pereira Alves; Lívia Maria Soares Nobre; Jand Venes Rolim Medeiros; Roberto Cesar Lima-Junior; Armênio Aguiar Dos Santos; Moisés Tolentino
Journal:  Inflammation       Date:  2020-10-31       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.